Clinical Trial: SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer

U.S., Aug. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07125950) titled 'SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer' on Aug. 06.

Brief Summary: Our study is aimed to evaluate the safety and preliminary of all-oral regimen SHR2554 combined with HRS-8080 or HRS-1358 in advanced breast cancer.

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Advanced Breast Cancer

Intervention: DRUG: SHR2554

SHR2554

DRUG: HRS-8080

HRS-8080

DRUG: HRS-1358

HRS-1358

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Henan Cancer Hospital

Information provided by (Responsible Party): Min Yan, MD, Henan Cancer Hospital

Disclaimer: Curated by HT Syndication....